Jocelyn Laurence is a clever analyst. I have to say I back the call that Biota is one of the future stars of Aussie biotech. Wish cash rolling in the door it's starting to get exciting... BTA has excellent management and research staff. The funds will go a long way to accelerate development of current programs and invest in other drugs.
Remember... CSL started as a small cap!
Go Biota!
